Company news

Supernus Pharmaceuticals, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Supernus Provides Business Update

March 29, 2020

Supernus to Present at the 2020 Cowen Health Care Conference

February 25, 2020

Supernus Announces Fourth Quarter and Full Year 2019 Financial Results

February 24, 2020

Supernus to Host Fourth Quarter and Full Year 2019 Results Earnings Conference Call

February 10, 2020

Supernus Announces FDA Acceptance for Review of New Drug Application for SPN-812 for the Treatment of ADHD

January 20, 2020

Supernus to Present at the 2020 J.P. Morgan Healthcare Conference

January 7, 2020

Supernus Provides Update on Results from Phase III Study (P301) of SPN-810 for Treatment of Impulsive Aggression (IA) in ADHD Patients

December 8, 2019

Supernus Submits New Drug Application for SPN-812 for the Treatment of ADHD

November 10, 2019

Supernus Announces Third Quarter 2019 Financial Results and Topline Data from Phase III Study of SPN-810 for Treatment of Impulsive Aggression (IA) in ADHD Patients

November 4, 2019

Supernus to Host Third Quarter 2019 Earnings Conference Call

October 23, 2019

Supernus to Present at the 2019 Cantor Global Healthcare Conference

September 24, 2019

← Newer news releases

Calls

The 5 newest of 25 calls. Every call is listed under its year.

Decks

The 5 newest of 17 decks. Every deck is listed under its year.